Direct medical costs for patients seeking emergency care for losses of epilepsy control in a U.S. managed care setting.
The objective of this retrospective claims database study was to compare the costs of care from a U.S. payer perspective before and after epilepsy treatment in emergent care settings and, secondarily, to describe the frequency of toxic effects and physical injuries occurring on the date of the emergent care. Nine and four-tenths percent of patients receiving emergent care for epilepsy (114/1213) had an injury or adverse antiepileptic drug effect on the same date. The majority of incidents were superficial injuries and contusions (28%), fractures (21%), open wounds or injury to blood vessels (19%), intracranial injury (10%), and/or medication toxicity (10%). Both non-epilepsy-related (US$12,745.56) and epilepsy-related (US$2013.62) direct medical costs of care pre-index were significantly different from those post-index (US$15,274.95 and US$7087.53, respectively). The cost of care for possible reestablishment of epilepsy control and treatment of co-occurring injuries is significant when compared with that for the period prior to seizure.
Zachry
Woodie M
WM
Abbott Laboratories, Abbott Park, IL 60064, USA. woodie.zachry@abbott.com
Doan
Quynhchau D
QD
Smith
Brien J
BJ
Clewell
Jerry D
JD
Griffith
Jenny M
JM
D000328:Adult; D016208:Databases, Factual / Q000706:statistics & numerical data; D004632:Emergency Medical Services / Q000191:economics*; D004827:Epilepsy / Q000191:economics / Q000628:therapy; D005260:Female; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D007345:Insurance Claim Review / Q000191:economics / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D014481:United States; D055815:Young Adult